Treatment patterns and outcomes of immunotherapy in extensive-stage small-cell lung cancer based on real-world practice.

First-line ICIs plus chemotherapy should be applied in the clinical practice of ES-SCLC. If patients did not receive ICIs plus chemotherapy in first-line treatment, therapies that include ICIs in second-line treatment should be considered.